rag2riches
Posted - 1 hour ago
$ONCT pumpers are here. Come on let's see which one of you has the strongest discord chat. Marketcap and float is puny so if you chats had any weight you should be able to move this and cause a short squeeze
LuckyCs
Posted - 2 hours ago
$ONCT It can go! 🧐
Bobby_J_Bomb
Posted - 2 hours ago
$ONCT how cool would it be to fill this pattern with a mid to late December Xmas gift announcement? They have $4 cash/share, only 3 mm shares and 10% inside ownership!!
LuckyCs
Posted - 3 hours ago
$ONCT 💪
Bobby_J_Bomb
Posted - 4 hours ago
$ONCT Filed last week that they are getting rid of the rest of their employees and keeping 4 part time. $2.4 mm cost associated with this, essentially leaving $12.1 mm, not including any other costs in the quarter, which they state are minimal. This would be around $4/share, not including any sales of assets or IP. Pretty decent R/R here for a 100%+ gain in a couple months. https://investor.oncternal.com/static-files/79f8d542-4566-4995-9d66-ed2f884dbdd1
Bobby_J_Bomb
Posted - 2 days ago
$ONCT How long does this review take? In the meantime, how about distributing cash while we wait to see if we can flip any of the clinical assets or technology!
rag2riches
Posted - 1 week ago
$ONCT who caught that dip? You would be up close to 30%. Much more room to go
rag2riches
Posted - 1 week ago
$ONCT just bought 4.6k shares to average down. Fuck it. Pumpers might be coming back soon to pick up these cheapies
HoHoHoHum
Posted - 1 week ago
$ONCT testing the lows today!
pablin
Posted - 1 week ago
$ONCT Gentlemen, Do you think we are going to know the outcome before the end of the year???
zoomlik
Posted - 1 week ago
$ONCT Best deal here is a RM (valuing compay at say $10M) and then a CVR for asset sale to split proceeds 50:50 by acquiring company and CVR holders
SDBiotechInvestor
Posted - 2 weeks ago
$ONCT Hearing BioTechValues going to rebuy the shares he dumped on y'all today tomorrow morning. This guy is just as bad as his master Donald Trump
joe77w
Posted - 2 weeks ago
$ONCT cash on hand 4.5 USD per share, net equity 3 USD, not accounting for 4 compounds available for potential monetization plus NASDAQ listing worth Upto 10 mln USD for reverse merger.
1/3 months and we could get positive news imo, worst case scenario liquidation around 1.5/2 USD per share Do your due diligence before investing your Money this Is not a financial advice
STR33
Posted - 2 weeks ago
$ONCT tax loss evidence...
pablin
Posted - 2 weeks ago
$ONCT I hate this management The are truly liers
SDBiotechInvestor
Posted - 2 weeks ago
$ONCT -
SDBiotechInvestor
Posted - 2 weeks ago
$ONCT 10Q. No commentary of timing or any progress in terms of asset sales. Probably a long road here.
BiotechValues
Posted - 2 weeks ago
$ONCT So $14.6M cash and burn is now probably ~$3M in q4. Trading around liquidation value. Free call option on the asset sales. Continue to reiterate that in 10q: "On September 12, 2024, the Company announced that its Board decided to discontinue the Company’s clinical trials evaluating ONCT-534 and ONCT-808 as well as all other product development activities, and to begin exploring strategic alternatives to maximize the value of the Company’s assets for its stockholders. The Company commenced a reduction-in-force beginning in September 2024, and is continuing to assess further cost reduction measures as its operational and strategic direction evolves. As part of the review of strategic alternatives, the Company may consider options such as asset sales or out-licensing opportunities for existing programs and merger, reverse merger or other business combination opportunities."
joe77w
Posted - 2 weeks ago
$ONCT if assets (4 Compounds) sold for total meager 10 mln USD and a reverse merger engeneered stock Could go to 8 USD because 10 mln USD would be nearly 3.35 USD per share, add net cash position around 5 mln (estimated) or 1.67 USD per share plus NASDAQ listing worth around 10 mln USD 3.35 USD again...8.85 USD if Company able to monetize assets for 10 mln if Company cash net of liabilities 4.5 mln usd and if reverse merger deal done...
8.37 would be worth around 25 mln USD with Os around 3 mln
Without reverse merger and in case of liquidation and dissolution assuming costs and a 3 Years lenghty process, my estimate would be lower, around 4 usd
Just pure speculation, do your DD before investing your Money, this Is not a financial advice!
Worst scenario imo liquidation around 4 mln USD or 1.42 USD per share
BiotechValues
Posted - 2 weeks ago
$ONCT should be getting the 10q any day now. Will see if they say anything in regards to the asset sale process that has been ongoing for ~ 2 months now. Reminder, that CFO in early Oct said this will be a fast/efficient process, with potential outcomes over a couple/few months
Brendalikesthestock
Posted - 2 weeks ago
$ONCT bullish
BiotechValues
Posted - 10/31/24
$ONCT they seem pretty happy with last week's surprise news:
BiotechValues
Posted - 10/31/24
$ONCT obviously the big recent development was the news that they were starting to see efficacy with ONCT-534 in the N=6 "twice daily dosing" cohorts. Maybe adds value/interest to the asset sale process for that asset https://investor.oncternal.com/news-releases/news-release-details/oncternal-therapeutics-announces-updated-safety-and-efficacy
BiotechValues
Posted - 10/31/24
$ONCT back to the $1.40s level, same area it was at before it popped to $2.30s last week. I'm a buyer here. Should get q3 update next week and hopefully some commentary on the status of the asset sale process. Thesis: https://x.com/BioValues/status/1847371756077797563
bbonct
Posted - 10/29/24
$ONCT so, any value in having a patent? Even after you discontinue the therapy?
PatentGrants
Posted - 10/29/24
$ONCT Oncternal Therapeutics has been granted US patent number 12,128,026 titled "Selective androgen receptor degrader ligands and methods of use thereof (for the treatment of prostate cancer)". https://ppubs.uspto.gov/pubwebapp/external.html?q=(12128026).pn.
joe77w
Posted - 10/29/24
$ONCT trying to sell and/or outlicensed, drug seems have value
justiceforb_85
Posted - 10/29/24
$ONCT bit confused by the messaging from the company. They are discontinuing development of ONCT-534 but see value in the therapy?
Bobby_J_Bomb
Posted - 10/29/24
$ONCT done building!!! $VSTM Sold 30% Holding 25k long $VTGN Building $AADI Holding for data $SPRB Holding for data